Ginsenoside Rd Anti-Inflammatory Drug Formulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-inflammatory drugs, such as non-steroidal and steroidal anti-inflammatory drugs, have adverse reactions and side effects, necessitating the search for novel anti-inflammatory agents with unique mechanisms.
Innovation Solution
Ginsenoside Rd, extracted from Radix Ginseng, is formulated into an anti-inflammatory drug or health food/medicinal and edible food/functional food/dietary supplement, combining it with pharmaceutically acceptable carriers and other active ingredients to create various dosage forms, offering a new application for its anti-inflammatory properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If non-steroidal anti-inflammatory drugs are used, then anti-inflammatory effect is improved, but gastric mucosal injuries, liver and kidney damages occur
Solution Approach 1:
The patent extracts and isolates ginsenoside Rd as a specific active component from ginseng, separating it from the complex mixture of ginseng compounds. This extraction allows for targeted anti-inflammatory therapy while avoiding the harmful effects associated with conventional NSAIDs, as ginsenoside Rd acts through a different mechanism (inhibiting NF-κB pathway) that does not cause gastric or organ damage.
Solution Approach 2:
Ginsenoside Rd serves as a natural intermediary substance that mediates anti-inflammatory effects through the NF-κB signaling pathway. Unlike conventional NSAIDs that directly inhibit cyclooxygenase enzymes, ginsenoside Rd acts as a natural mediator that modulates the immune response and inflammatory cascade through cellular signaling, thereby achieving anti-inflammatory effects without the harsh side effects of synthetic drugs.
2Reliability
If steroidal anti-inflammatory drugs (glucocorticoids) are used, then anti-inflammatory effect is improved, but water and sodium retention occurs
Solution Approach 1:
The patent extracts ginsenoside Rd as a specific non-steroidal anti-inflammatory agent, separating it from both conventional NSAIDs and steroidal anti-inflammatory drugs. This extraction enables the use of a plant-derived compound that achieves anti-inflammatory effects through natural pathways without the water and sodium retention side effects characteristic of glucocorticoids.
Solution Approach 2:
The patent changes the chemical and mechanistic parameters of anti-inflammatory therapy by using ginsenoside Rd, a triterpenoid saponin with a completely different molecular structure and mechanism of action compared to glucocorticoids. Ginsenoside Rd inhibits the NF-κB pathway and modulates cytokine production, representing a fundamental parameter change from steroid-based anti-inflammatory mechanisms, thereby avoiding steroid-related side effects.
3Reliability
If long-term massive use of anti-inflammatory drugs is made, then anti-inflammatory effect is maintained, but tolerances and adverse reactions occur
Solution Approach 1:
Ginsenoside Rd enables the body's immune system to regulate itself through natural anti-inflammatory pathways. Rather than forcing suppression through conventional drugs, ginsenoside Rd modulates the immune response and promotes endogenous resolution of inflammation, allowing for long-term use without inducing tolerances or severe adverse reactions. The compound works synergistically with the body's own regulatory mechanisms.
Solution Approach 2:
The patent introduces a fundamentally different mechanism of action parameter - ginsenoside Rd modulates multiple inflammatory pathways including NF-κB inhibition, cytokine regulation, and immune cell modulation, rather than simply blocking prostaglandin synthesis or suppressing immune function. This multi-parameter modulation approach maintains efficacy over long-term use without inducing the tolerances and adverse reactions seen with conventional drugs.
Data Source
AI summary
The present invention discloses a novel application of ginsenoside Rd in preparation of a drug for relieving or/and treating inflammations and health food/medicinal and edible food/functional food/dietary supplement. Tests prove that ginsenoside Rd has a remarkable curative effect on inflammations, takes effect quickly, has a better effect than Dexamethasone, is suitable for both acute inflammations such as influenza virus pneumonia, novel coronavirus pneumonia and acute lung injury inflammations, and chronic inflammations such as chronic obstructive pneumonia and chronic asthmatic airway inflammations, and is regarded as a new drug source for treating acute and chronic inflammations and complications thereof.